INITIAL CLINICAL EXPERIENCE WITH I.C.I. 66.082, A NEW β‐ADRENERGIC BLOCKING AGENT, IN HYPERTENSION.

Abstract
No abstract available

This publication has 4 references indexed in Scilit: